Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet + Ifosfamide in Metastatic Soft Tissue Sarcoma
NCT00289809Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Sep 2006
- Primary completion
- Dec 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in soft tissue sarcoma (STS), sponsored by Humanitas Research Hospital. Started Sep 2006; status: completed.
02
Drugs
doxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00289809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289809.